About 7 results found for searched term "TLR7 agonist 9" (0.13 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M42073 | TLR7 agonist 9 | TLR |
| TLR7 agonist 9 is an aonist of TLR7. | ||
| M2728 | Vesatolimod (GS-9620) | TLR |
| GS9620 | ||
| Vesatolimod (GS-9620) is an effective, selective, oral toll-like receptor 7 (TLR7) agonist with an EC50 value of 291 nM. | ||
| M10824 | GSK2245035 | TLR |
| GSK2245035 is a highly potent, selective intranasal Toll-Like receptor 7 (TLR7) agonist with preferential stimulation of interferon type 1 (IFN). GSK2245035 for IFNα and TNFα pEC50 9.3 and 6.5, respectively. GSK2245035 effectively inhibits allergen-induced Th2 cytokine production in human peripheral blood cell cultures. GSK2245035 has the potential for asthma. | ||
| M11411 | 1V209 | TLR |
| TLR7 agonist T7 | ||
| 1V209 (TLR7 agonist T7) is a Toll-like receptor 7 (TLR7) agonist with antitumor effects. 1V209 can be conjugated with various polysaccharides to improve their water solubility, enhance efficacy and maintain low toxicity. | ||
| M21418 | CL097 | TLR |
| CL097 is a potent TLR7 and TLR8 agonist that induces pro-inflammatory cytokines in macrophages.CL097 induces NADPH oxidase initiating activity leading to increased fMLF-stimulated ROS production. | ||
| M27993 | BBIQ | TLR |
| BBIQ is a imidazoquinoline compound and a potent and selectively toll-like receptor 7 (TLR7) agonist with an EC50 of 59.1 nM for human TLR7. BBIQ is a powerful vaccine adjuvant that enhances innate immune responses. | ||
| M42071 | TLR7/8/9 antagonist 2 | TLR |
| TLR7/8/9 antagonist 2 is an orally active TLR7/8/9 antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
